Vit-D receptor (VDR) agonists can inhibit proliferation, induce differentiation, aggravate apoptosis and decrease pro-inflammatory cytokines production in hematologic malignancies and also have a synergistic effect with some chemotherapeutic drugs (22, 33). This evidence concerns the gene VDR and hematologic disorder.